|1.||Lin, Jiayuh: 3 articles (01/2008 - 03/2005)|
|2.||Chan, Christina: 2 articles (01/2008 - 01/2007)|
|3.||Cheng, Gong: 2 articles (01/2008 - 01/2007)|
|4.||Hsieh, Fu-Chuan: 2 articles (01/2008 - 01/2007)|
|5.||Loy, Abbey: 2 articles (01/2008 - 01/2007)|
|6.||Cen, Ling: 2 articles (01/2008 - 01/2007)|
|7.||Chen, Chun-Liang: 2 articles (01/2008 - 01/2007)|
|8.||Cho, Mi-La: 1 article (04/2014)|
|9.||Ryu, Jun-Geol: 1 article (04/2014)|
|10.||Kim, Eun-Kyung: 1 article (04/2014)|
04/01/2014 - "STA-21 improved the clinical course of arthritis in IL-1Ra-KO mice. "
04/01/2014 - "STA-21 suppressed inflammatory arthritis in IL-1Ra-KO mice. "
04/01/2014 - "To investigate the impact of STA-21, a promising STAT-3 inhibitor, on the development and progression of inflammatory arthritis and to determine the possible mechanisms by which STA-21 has antiarthritic effects in interleukin-1 receptor antagonist-knockout (IL-1Ra-KO) mice, an animal model of rheumatoid arthritis (RA). "
|2.||Psoriasis (Pustulosis Palmaris et Plantaris)
01/01/2011 - "In this study, we examined whether STA-21, a small Stat3 inhibitor, could be useful in ameliorating the skin lesions not only in the model mouse but also in human psoriasis. "
01/01/2011 - "Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor."
|3.||Glioblastoma (Glioblastoma Multiforme)
01/13/2009 - "In this study, we investigated the inhibitory effects of a small molecule compound known as LLL-3, which is a structural analogue of the earlier reported STAT3 inhibitor, STA-21, on the cell viability of human glioblastoma cells, U87, U373, and U251 expressing constitutively activated STAT3. "
01/01/2014 - "Treatment of the cocultured MSCs and glioma cells with STA-21, to block the constitutive STAT3 signaling, reduced the risk of MSC tumor-like transformation in the tumor microenvironment. "
09/01/2011 - "We also review the rationale to use novel STAT3 inhibitors and list some of these inhibitors such as STA-21, IS3 295, S3I- M2001 and small molecule JAK2 inhibitors AZD1480 and AZ960 that have been found to be efficient against tumors. "
|5.||Sarcoma (Soft Tissue Sarcoma)
|2.||Interleukin-1 (Interleukin 1)